Gary Levine Long

US Patent:

20210236815, Aug 5, 2021

Filed:

Mar 25, 2021

Appl. No.:

17/212833

Inventors:

- San Carlos CA, US
William S. Krimsky - Forest Hill MD, US
Denise M. Zarins - Saratoga CA, US
Robert J. Beetel - Sunnyvale CA, US
Paul Brian Friedrichs - Belmont CA, US
Kevin James Taylor - San Mateo CA, US
Roman Turovskiy - San Francisco CA, US
Gary L. Long - Cincinnati OH, US

Assignee:

Galary, Inc. - San Carlos CA

International Classification:

A61N 1/32
A61N 1/05

Abstract:

Apparatuses, systems and methods are provided for treating pulmonary tissues via delivery of energy, generally characterized by high voltage pulses, to target tissue using a pulmonary tissue modification system (e.g., an energy delivery catheter system). Example pulmonary tissues include, without limitation, those within the respiratory tract, particularly the epithelium (the goblet cells, ciliated pseudostratified columnar epithelial cells, and basal cells), lamina propria, submucosa, submucosal glands, basement membrane, smooth muscle, cartilage, nerves, pathogens resident near or within the tissue, or a combination of any of these. The systems may be used to treat pathogens, such as bacteria and viruses, particularly coronaviruses.

US Patent:

20210236816, Aug 5, 2021

Filed:

Mar 26, 2021

Appl. No.:

17/214688

Inventors:

- San Carlos CA, US
William Sanford Krimsky - Forest Hill MD, US
Denise M. Zarins - Saratoga CA, US
Robert J. Beetel - Sunnyvale CA, US
Paul Brian Friedrichs - Belmont CA, US
Kevin James Taylor - San Mateo CA, US
Roman Turovskiy - San Francisco CA, US
Gary L. Long - Cincinnati OH, US

Assignee:

Galary, Inc. - San Carlos CA

International Classification:

A61N 1/32
A61N 1/06

Abstract:

Apparatuses, systems and methods are provided for treating pulmonary tissues via delivery of energy, generally characterized by high voltage pulses, to target tissue using a pulmonary tissue modification system (e.g., an energy delivery catheter system). Example pulmonary tissues include, without limitation, the epithelium (the goblet cells, ciliated pseudostratified columnar epithelial cells, and basal cells), lamina propria, submucosa, submucosal glands, basement membrane, smooth muscle, cartilage, nerves, pathogens resident near or within the tissue, or a combination of any of these. The system may be used to treat a variety of pulmonary diseases or disorders such as or associated with COPD (e.g., chronic bronchitis, emphysema), asthma, interstitial pulmonary fibrosis, cystic fibrosis, bronchiectasis, primary ciliary dyskinesia (PCD), acute bronchitis and/or other pulmonary diseases or disorders.

US Patent:

20210146126, May 20, 2021

Filed:

Jun 26, 2020

Appl. No.:

16/914072

Inventors:

- Menlo Park CA, US
William Sanford Krimsky - Forest Hill MD, US
Denise M. Zarins - Saratoga CA, US
Robert J. Beetel - Sunnyvale CA, US
Paul Brian Friedrichs - Belmont CA, US
Kevin James Taylor - San Mateo CA, US
Roman Turovskiy - San Francisco CA, US
Gary L. Long - Cincinnati OH, US

Assignee:

Galary, Inc. - Menlo Park CA

International Classification:

A61N 1/32
A61N 1/06

Abstract:

Apparatuses, systems and methods are provided for treating pulmonary tissues via delivery of energy, generally characterized by high voltage pulses, to target tissue using a pulmonary tissue modification system (e.g., an energy delivery catheter system). Example pulmonary tissues include, without limitation, the epithelium (the goblet cells, ciliated pseudostratified columnar epithelial cells, and basal cells), lamina propria, submucosa, submucosal glands, basement membrane, smooth muscle, cartilage, nerves, pathogens resident near or within the tissue, or a combination of any of these. The system may be used to treat a variety of pulmonary diseases or disorders such as or associated with COPD (e.g., chronic bronchitis, emphysema), asthma, interstitial pulmonary fibrosis, cystic fibrosis, bronchiectasis, primary ciliary dyskinesia (PCD), acute bronchitis and/or other pulmonary diseases or disorders.

US Patent:

20200323586, Oct 15, 2020

Filed:

Jun 10, 2020

Appl. No.:

16/898320

Inventors:

- Menlo Park CA, US
William Sanford KRIMSKY - Forest Hill MD, US
Denise Marie ZARINS - Saratoga CA, US
Paul Brian FRIEDRICHS - Belmont CA, US
Kevin James TAYLOR - San Mateo CA, US
Roman TUROVSKIY - San Francisco CA, US
Gary L. LONG - Cincinnati OH, US

Assignee:

Galary, Inc. - Menlo Park CA

International Classification:

A61B 18/14
A61B 18/12
A61N 1/06
A61N 1/32

Abstract:

Apparatuses, systems and methods are provided for treating pulmonary tissues via delivery of energy, generally characterized by high voltage pulses, to target tissue using a pulmonary tissue modification system (e.g., an energy delivery catheter system). Example pulmonary tissues include, without limitation, the epithelium (the goblet cells, ciliated pseudostratified columnar epithelial cells, and basal cells), lamina propria, submucosa, submucosal glands, basement membrane, smooth muscle, cartilage, nerves, pathogens resident near or within the tissue, or a combination of any of these. The system may be used to treat a variety of pulmonary diseases or disorders such as or associated with COPD (e.g., chronic bronchitis, emphysema), asthma, interstitial pulmonary fibrosis, cystic fibrosis, bronchiectasis, primary ciliary dyskinesia (PCD), acute bronchitis and/or other pulmonary diseases or disorders.

US Patent:

20190231425, Aug 1, 2019

Filed:

Apr 11, 2019

Appl. No.:

16/381745

Inventors:

- New York NY, US
William Sanford KRIMSKY - Forest Hill MD, US
Denise Marie ZARINS - Saratoga CA, US
Paul Brian FRIEDRICHS - Belmont CA, US
Kevin James TAYLOR - San Mateo CA, US
Roman TUROVSKIY - San Francisco CA, US
Gary L. LONG - Cincinnati OH, US

Assignee:

Gala Therapeutics, Inc. - New York NY

International Classification:

A61B 18/14
A61B 18/12

Abstract:

Apparatuses, systems and methods are provided for treating pulmonary tissues via delivery of energy, generally characterized by high voltage pulses, to target tissue using a pulmonary tissue modification system (e.g., an energy delivery catheter system). Example pulmonary tissues include, without limitation, the epithelium (the goblet cells, ciliated pseudostratified columnar epithelial cells, and basal cells), lamina propria, submucosa, submucosal glands, basement membrane, smooth muscle, cartilage, nerves, pathogens resident near or within the tissue, or a combination of any of these. The system may be used to treat a variety of pulmonary diseases or disorders such as or associated with COPD (e.g., chronic bronchitis, emphysema), asthma, interstitial pulmonary fibrosis, cystic fibrosis, bronchiectasis, primary ciliary dyskinesia (PCD), acute bronchitis and/or other pulmonary diseases or disorders.

US Patent:

20190201089, Jul 4, 2019

Filed:

Dec 20, 2018

Appl. No.:

16/227796

Inventors:

- New York NY, US
William Sanford KRIMSKY - Forest Hill MD, US
Denise Marie ZARINS - Saratoga CA, US
Paul Brian FRIEDRICHS - Belmont CA, US
Kevin James TAYLOR - San Mateo CA, US
Roman TUROVSKIY - San Francisco CA, US
Gary L. LONG - Cincinnati OH, US

International Classification:

A61B 18/14
A61B 18/12

Abstract:

Apparatuses, systems and methods are provided for treating pulmonary tissues via delivery of energy, generally characterized by high voltage pulses, to target tissue using a pulmonary tissue modification system (e.g., an energy delivery catheter system). Example pulmonary tissues include, without cells), lamina propria, submucosa, submucosal glands, basement membrane, smooth muscle, cartilage, nerves, pathogens resident near or within the tissue, or a combination of any of these. The system may be used to treat a variety of pulmonary diseases or disorders such as or associated with COPD (e.g., chronic bronchitis, emphysema), asthma, interstitial pulmonary fibrosis, cystic fibrosis, bronchiectasis, primary ciliary dyskinesia (PCD), acute bronchitis and/or other pulmonary diseases or disorders.